{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:00:11Z","timestamp":1791291611651,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000},"content-version":"vor","delay-in-days":5485,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1111\/j.1538-7836.2007.02762.x","type":"journal-article","created":{"date-parts":[[2007,11,19]],"date-time":"2007-11-19T23:08:49Z","timestamp":1195513729000},"page":"2399-2407","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"title":["T\u2010cell responses over time in a mild hemophilia A inhibitor subject: epitope identification and transient immunogenicity of the corresponding self\u2010peptide"],"prefix":"10.1016","volume":"5","author":[{"given":"E.A.","family":"JAMES","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.W.","family":"KWOK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.A.","family":"ETTINGER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.R.","family":"THOMPSON","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.P.","family":"PRATT","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2007.02762.x_bb0010","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/j.1538-7836.2004.00802.x","article-title":"Pathogenic antibodies to coagulation factors. Part one: factor VIII and factor IX","volume":"2","author":"Lollar","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02762.x_bb0015","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/0140-6736(92)90874-3","article-title":"Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs","volume":"339","author":"Ehrenforth","year":"1992","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2007.02762.x_bb0020","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1056\/NEJM199302183280701","article-title":"Recombinant factor VIII for the treatment of previously untreated patients with hemophilia A. Safety, efficacy, and development of inhibitors. Kogenate Previously Untreated Patient Study Group","volume":"328","author":"Lusher","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2007.02762.x_bb0025","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1046\/j.1538-7836.2004.00710.x","article-title":"The incidence of factor VIII and factor IX inhibitors in the hemophilia population of the UK and their effect on subsequent mortality, 1977\u201399","volume":"2","author":"Darby","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02762.x_bb0030","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1182\/blood.V90.5.1902","article-title":"Loss of tolerance to exogenous and endogenous factor VIII in a mild hemophilia A patient with an Arg593 to Cys mutation","volume":"90","author":"Thompson","year":"1997","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2007.02762.x_bb0035","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.1182\/blood.V89.12.4371","article-title":"The missense mutation Arg593\u2010Cys is related to antibody formation in a patient with mild hemophilia A","volume":"89","author":"Fijnvandraat","year":"1997","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2007.02762.x_bb0040","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1046\/j.1365-2516.1998.440558.x","article-title":"Factor VIII inhibitors in mild and moderate\u2010severity haemophilia A","volume":"4","author":"Hay","year":"1998","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2007.02762.x_bb0045","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1182\/blood.V93.7.2267","article-title":"Antifactor VIII antibody inhibiting allogeneic but not autologous factor VIII in patients with mild hemophilia A","volume":"93","author":"Peerlinck","year":"1999","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2007.02762.x_bb0050","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1182\/blood-2002-05-1369","article-title":"CD4+ T\u2010cell clones specific for wild\u2010type factor VIII: a molecular mechanism responsible for a higher incidence of inhibitor formation in mild\/moderate hemophilia A","volume":"101","author":"Jacquemin","year":"2003","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2007.02762.x_bb0055","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1046\/j.1538-7836.2003.00230.x","article-title":"Intensive exposure to factor VIII is a risk factor for inhibitor development in mild hemophilia A","volume":"1","author":"Sharathkumar","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02762.x_bb0060","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1111\/j.1538-7836.2005.01375.x","article-title":"Cellular immune responses in hemophilia: why do inhibitors develop in some, but not all hemophiliacs?","volume":"3","author":"White","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"Suppl. 6","key":"10.1111\/j.1538-7836.2007.02762.x_bb0065","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2516.2006.01365.x","article-title":"Characteristics of inhibitors in mild\/moderate haemophilia A","volume":"12","author":"Peerlinck","year":"2006","journal-title":"Haemophilia"},{"issue":"Suppl. 6","key":"10.1111\/j.1538-7836.2007.02762.x_bb0070","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2516.2006.01361.x","article-title":"Genetic risk factors for inhibitors to factors VIII and IX","volume":"12","author":"Oldenburg","year":"2006","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2007.02762.x_bb0075","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1055\/s-0037-1614450","article-title":"Inhibitor antibody development and T cell response to human factor VIII in murine hemophilia A","volume":"81","author":"Qian","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02762.x_bb0080","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1160\/TH03-12-0755","article-title":"Immunodominant T\u2010cell epitopes in the factor VIII C2 domain are located within an inhibitory antibody binding site","volume":"92","author":"Pratt","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02762.x_bb0085","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1111\/j.1538-7836.2006.02118.x","article-title":"Induction of partial immune tolerance to factor VIII through prior mucosal exposure to the factor VIII C2 domain","volume":"4","author":"Rawle","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02762.x_bb0090","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1046\/j.1538-7836.2003.00366.x","article-title":"Recognition of coagulation factor VIII by CD4+ T cells of healthy humans","volume":"1","author":"Hu","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02762.x_bb0095","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1055\/s-0037-1615873","article-title":"CD4+ T cell response to factor VIII in hemophilia A, acquired hemophilia, and healthy subjects","volume":"82","author":"Reding","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02762.x_bb0100","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1365-2141.1990.tb07878.x","article-title":"Histocompatibility antigen patterns in haemophilic patients with factor VIII antibodies","volume":"76","author":"Aly","year":"1990","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2007.02762.x_bb0105","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1055\/s-0038-1655944","article-title":"HLA class II profile: a weak determinant of factor VIII inhibitor development in severe haemophilia A. UKHCDO Inhibitor Working Party","volume":"77","author":"Hay","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02762.x_bb0110","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1055\/s-0038-1655945","article-title":"HLA genotype of patients with severe haemophilia A due to intron 22 inversion with and without inhibitors of factor VIII","volume":"77","author":"Oldenburg","year":"1997","journal-title":"Thromb Haemost"},{"issue":"Suppl. 4","key":"10.1111\/j.1538-7836.2007.02762.x_bb0115","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1365-2516.2004.01009.x","article-title":"Inhibitors in haemophilia: pathophysiology","volume":"10","author":"Saint\u2010Remy","year":"2004","journal-title":"Haemophilia"},{"issue":"Suppl. 6","key":"10.1111\/j.1538-7836.2007.02762.x_bb0120","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2516.2006.01363.x","article-title":"Immunological aspects of inhibitor development","volume":"12","author":"Reding","year":"2006","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2007.02762.x_bb0125","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/j.1538-7836.2005.01309.x","article-title":"Identification and removal of a promiscuous CD4+ T cell epitope from the C1 domain of factor VIII","volume":"3","author":"Jones","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02762.x_bb0130","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1111\/j.1538-7836.2004.00918.x","article-title":"T cell recognition of the A2 domain of coagulation factor VIII in hemophilia patients and healthy subjects","volume":"2","author":"Hu","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02762.x_bb0135","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1111\/j.1538-7836.2004.00850.x","article-title":"Epitope repertoire of human CD4(+) T cells on the A3 domain of coagulation factor VIII","volume":"2","author":"Reding","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02762.x_bb0140","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1046\/j.1538-7836.2003.00251.x","article-title":"Human CD4+ T\u2010cell epitope repertoire on the C2 domain of coagulation factor VIII","volume":"1","author":"Reding","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02762.x_bb0145","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1055\/s-0037-1614081","article-title":"Sensitization of CD4+ T cells to coagulation factor VIII: response in congenital and acquired hemophilia patients and in healthy subjects","volume":"84","author":"Reding","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02762.x_bb0150","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0076-6879(93)22011-4","article-title":"Characterization of factor IX defects in hemophilia B patients","volume":"222","author":"Thompson","year":"1993","journal-title":"Methods Enzymol"},{"key":"10.1111\/j.1538-7836.2007.02762.x_bb0155","first-page":"612","article-title":"Proceedings: a more uniform measurement of factor VIII inhibitors","volume":"34","author":"Kasper","year":"1975","journal-title":"Thromb Diath Haemorrh"},{"key":"10.1111\/j.1538-7836.2007.02762.x_bb0160","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/46601","article-title":"Structure of the C2 domain of human factor VIII at 1.5 A resolution","volume":"402","author":"Pratt","year":"1999","journal-title":"Nature"},{"key":"10.1111\/j.1538-7836.2007.02762.x_bb0165","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1055\/s-0037-1613463","article-title":"The preparation and phospholipid binding property of the C2 domain of human factor VIII","volume":"89","author":"Takeshima","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02762.x_bb0170","doi-asserted-by":"crossref","first-page":"R63","DOI":"10.1172\/JCI8476","article-title":"MHC class II tetramers identify peptide\u2010specific human CD4(+) T cells proliferating in response to influenza A antigen","volume":"104","author":"Novak","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1538-7836.2007.02762.x_bb0175","doi-asserted-by":"crossref","first-page":"5967","DOI":"10.4049\/jimmunol.172.10.5967","article-title":"Autoreactive T cells in healthy individuals","volume":"172","author":"Danke","year":"2004","journal-title":"J Immunol"},{"key":"10.1111\/j.1538-7836.2007.02762.x_bb0180","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.clim.2006.03.008","article-title":"Multiplex mapping of CD4 T cell epitopes using class II tetramers","volume":"120","author":"Yang","year":"2006","journal-title":"Clin Immunol"},{"key":"10.1111\/j.1538-7836.2007.02762.x_bb0185","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.4049\/jimmunol.160.5.2365","article-title":"A peptide binding motif for HLA\u2010DQA1*0102\/DQB1*0602, the class II MHC molecule associated with dominant protection in insulin\u2010dependent diabetes mellitus","volume":"160","author":"Ettinger","year":"1998","journal-title":"J Immunol"},{"key":"10.1111\/j.1538-7836.2007.02762.x_bb0190","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.4049\/jimmunol.146.7.2331","article-title":"Single amino acid changes in DR and antigen define residues critical for peptide\u2010MHC binding and T cell recognition","volume":"146","author":"Krieger","year":"1991","journal-title":"J Immunol"},{"key":"10.1111\/j.1538-7836.2007.02762.x_bb0195","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2165\/00822942-200605010-00008","article-title":"MHCPred 2.0: an updated quantitative T\u2010cell epitope prediction server","volume":"5","author":"Guan","year":"2006","journal-title":"Appl Bioinformatics"},{"key":"10.1111\/j.1538-7836.2007.02762.x_bb0200","doi-asserted-by":"crossref","first-page":"14505","DOI":"10.1074\/jbc.270.24.14505","article-title":"Residues 484\u2010508 contain a major determinant of the inhibitory epitope in the A2 domain of human factor VIII","volume":"270","author":"Healey","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1538-7836.2007.02762.x_bb0205","doi-asserted-by":"crossref","first-page":"6152","DOI":"10.1073\/pnas.85.16.6152","article-title":"Epitope mapping of human factor VIII inhibitor antibodies by deletion analysis of factor VIII fragments expressed in Escherichia coli","volume":"85","author":"Scandella","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1538-7836.2007.02762.x_bb0210","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1182\/blood-2006-05-022756","article-title":"VWF protects FVIII from endocytosis by dendritic cells and subsequent presentation to immune effectors","volume":"109","author":"Dasgupta","year":"2007","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2007.02762.x_bb0215","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0022-1759(02)00201-6","article-title":"Use of class II tetramers for identification of CD4+ T cells","volume":"268","author":"Kwok","year":"2002","journal-title":"J Immunol Methods"},{"key":"10.1111\/j.1538-7836.2007.02762.x_bb0220","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.4049\/jimmunol.175.7.4255","article-title":"CD4+ CD25+ regulatory T cells inhibit the maturation but not the initiation of an autoantibody response","volume":"175","author":"Fields","year":"2005","journal-title":"J Immunol"},{"key":"10.1111\/j.1538-7836.2007.02762.x_bb0225","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1172\/JCI28941","article-title":"Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo","volume":"116","author":"Vukmanovic\u2010Stejic","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1538-7836.2007.02762.x_bb0230","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1538-7836.2007.02336.x","article-title":"Depletion of CD4+\/CD25high regulatory T cells may enhance or uncover factor VIII\u2010specific T\u2010cell responses in healthy individuals","volume":"5","author":"Kamate","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02762.x_bb0235","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2141.2006.06359.x","article-title":"Mechanisms of action of immune tolerance induction against factor VIII in patients with congenital haemophilia A and factor VIII inhibitors","volume":"136","author":"Reipert","year":"2007","journal-title":"Br J Haematol"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2007.02762.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622082770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622082770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2007.02762.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:39:19Z","timestamp":1761532759000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622082770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":46,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S1538783622082770"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2007.02762.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"T\u2010cell responses over time in a mild hemophilia A inhibitor subject: epitope identification and transient immunogenicity of the corresponding self\u2010peptide","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2007.02762.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}